Editorial
Clínica e Investigación en Arteriosclerosis has been assigned an impact factor: A goal achieved!
La asignación de factor impacto a Clínica e Investigación en Arteriosclerosis: ¡Un objetivo conseguido!
Josep Ribalta, Carlos Lahoz, Xavier Pintó
Read
64
Timeswas read the article
12
Total PDF
52
Total HTML
Share statistics
array:22 [ "pii" => "S2529912323000554" "issn" => "25299123" "doi" => "10.1016/j.artere.2023.07.007" "estado" => "S300" "fechaPublicacion" => "2023-07-01" "aid" => "684" "copyrightAnyo" => "2023" "documento" => "article" "crossmark" => 1 "subdocumento" => "sco" "cita" => "Clin Investig Arterioscler. 2023;35:201" "abierto" => array:3 [ "ES" => false "ES2" => false "LATM" => false ] "gratuito" => false "lecturas" => array:1 [ "total" => 0 ] "itemSiguiente" => array:19 [ "pii" => "S2529912323000487" "issn" => "25299123" "doi" => "10.1016/j.artere.2023.07.004" "estado" => "S300" "fechaPublicacion" => "2023-07-01" "aid" => "678" "copyright" => "The Authors" "documento" => "article" "crossmark" => 1 "subdocumento" => "sco" "cita" => "Clin Investig Arterioscler. 2023;35:202-5" "abierto" => array:3 [ "ES" => false "ES2" => false "LATM" => false ] "gratuito" => false "lecturas" => array:1 [ "total" => 0 ] "en" => array:11 [ "idiomaDefecto" => true "cabecera" => "<span class="elsevierStyleTextfn">Editorial</span>" "titulo" => "Pemafibrate: PROMINENT failure or an urgent need for therapeutic replacement?" "tienePdf" => "en" "tieneTextoCompleto" => "en" "paginas" => array:1 [ 0 => array:2 [ "paginaInicial" => "202" "paginaFinal" => "205" ] ] "titulosAlternativos" => array:1 [ "es" => array:1 [ "titulo" => "Pemafibrato: ¿un fracaso PROMINENTe o una necesidad urgente de reposicionamiento terapéutico?" ] ] "contieneTextoCompleto" => array:1 [ "en" => true ] "contienePdf" => array:1 [ "en" => true ] "resumenGrafico" => array:2 [ "original" => 0 "multimedia" => array:8 [ "identificador" => "fig0005" "etiqueta" => "Figure 1" "tipo" => "MULTIMEDIAFIGURA" "mostrarFloat" => true "mostrarDisplay" => false "figura" => array:1 [ 0 => array:4 [ "imagen" => "gr1.jpeg" "Alto" => 2961 "Ancho" => 1675 "Tamanyo" => 285456 ] ] "detalles" => array:1 [ 0 => array:3 [ "identificador" => "at0005" "detalle" => "Figure " "rol" => "short" ] ] "descripcion" => array:1 [ "en" => "<p id="spar0005" class="elsevierStyleSimplePara elsevierViewall">A. Classical PPARα receptor ligand: both ligands (fenofibrate and gemfibrozil) recruit the same transcription co-activators and produce similar effects. B. PPARα receptor modulator: pemafibrate shares coactivators with the classical ligand (fenofibrate), but also recruits different coactivators, thus presenting a different efficacy and safety profile to fenofibrate.</p>" ] ] ] "autores" => array:1 [ 0 => array:2 [ "autoresLista" => "Juan Carlos Laguna Egea, Núria Roglans Ribas, Roger Bentanachs Raset" "autores" => array:3 [ 0 => array:2 [ "nombre" => "Juan Carlos" "apellidos" => "Laguna Egea" ] 1 => array:2 [ "nombre" => "Núria" "apellidos" => "Roglans Ribas" ] 2 => array:2 [ "nombre" => "Roger" "apellidos" => "Bentanachs Raset" ] ] ] ] ] "idiomaDefecto" => "en" "Traduccion" => array:1 [ "es" => array:9 [ "pii" => "S0214916823000451" "doi" => "10.1016/j.arteri.2023.05.001" "estado" => "S300" "subdocumento" => "" "abierto" => array:3 [ "ES" => false "ES2" => false "LATM" => false ] "gratuito" => false "lecturas" => array:1 [ "total" => 0 ] "idiomaDefecto" => "es" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S0214916823000451?idApp=UINPBA00004N" ] ] "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S2529912323000487?idApp=UINPBA00004N" "url" => "/25299123/0000003500000004/v3_202311141613/S2529912323000487/v3_202311141613/en/main.assets" ] "itemAnterior" => array:19 [ "pii" => "S2529912323000451" "issn" => "25299123" "doi" => "10.1016/j.artere.2023.07.001" "estado" => "S300" "fechaPublicacion" => "2023-07-01" "aid" => "664" "copyright" => "Sociedad Española de Arteriosclerosis" "documento" => "article" "crossmark" => 1 "subdocumento" => "fla" "cita" => "Clin Investig Arterioscler. 2023;35:195-200" "abierto" => array:3 [ "ES" => false "ES2" => false "LATM" => false ] "gratuito" => false "lecturas" => array:1 [ "total" => 0 ] "en" => array:13 [ "idiomaDefecto" => true "cabecera" => "<span class="elsevierStyleTextfn">Original article</span>" "titulo" => "Cardiovascular risk factors and death in South America" "tienePdf" => "en" "tieneTextoCompleto" => "en" "tieneResumen" => array:2 [ 0 => "en" 1 => "es" ] "paginas" => array:1 [ 0 => array:2 [ "paginaInicial" => "195" "paginaFinal" => "200" ] ] "titulosAlternativos" => array:1 [ "es" => array:1 [ "titulo" => "Factores de riesgo y muerte cardiovascular en América del Sur" ] ] "contieneResumen" => array:2 [ "en" => true "es" => true ] "contieneTextoCompleto" => array:1 [ "en" => true ] "contienePdf" => array:1 [ "en" => true ] "resumenGrafico" => array:2 [ "original" => 0 "multimedia" => array:8 [ "identificador" => "fig0005" "etiqueta" => "Figure 1" "tipo" => "MULTIMEDIAFIGURA" "mostrarFloat" => true "mostrarDisplay" => false "figura" => array:1 [ 0 => array:4 [ "imagen" => "gr1.jpeg" "Alto" => 1101 "Ancho" => 3038 "Tamanyo" => 239594 ] ] "detalles" => array:1 [ 0 => array:3 [ "identificador" => "at0005" "detalle" => "Figure " "rol" => "short" ] ] "descripcion" => array:1 [ "en" => "<p id="spar0005" class="elsevierStyleSimplePara elsevierViewall">Risk factors with values of more than 2% population attributable fraction for cardiovascular disease (A) and for total mortality (B) in the South American population studied.</p>" ] ] ] "autores" => array:1 [ 0 => array:2 [ "autoresLista" => "Patricio López-Jaramillo, José P. López-López" "autores" => array:2 [ 0 => array:2 [ "nombre" => "Patricio" "apellidos" => "López-Jaramillo" ] 1 => array:2 [ "nombre" => "José P." "apellidos" => "López-López" ] ] ] ] ] "idiomaDefecto" => "en" "Traduccion" => array:1 [ "es" => array:9 [ "pii" => "S0214916822001358" "doi" => "10.1016/j.arteri.2022.12.001" "estado" => "S300" "subdocumento" => "" "abierto" => array:3 [ "ES" => false "ES2" => false "LATM" => false ] "gratuito" => false "lecturas" => array:1 [ "total" => 0 ] "idiomaDefecto" => "es" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S0214916822001358?idApp=UINPBA00004N" ] ] "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S2529912323000451?idApp=UINPBA00004N" "url" => "/25299123/0000003500000004/v3_202311141613/S2529912323000451/v3_202311141613/en/main.assets" ] "en" => array:10 [ "idiomaDefecto" => true "cabecera" => "<span class="elsevierStyleTextfn">Editorial</span>" "titulo" => "Clínica e Investigación en Arteriosclerosis has been assigned an impact factor: A goal achieved!" "tieneTextoCompleto" => true "paginas" => array:1 [ 0 => array:1 [ "paginaInicial" => "201" ] ] "autores" => array:1 [ 0 => array:2 [ "autoresLista" => "Josep Ribalta, Carlos Lahoz, Xavier Pintó" "autores" => array:3 [ 0 => array:2 [ "nombre" => "Josep" "apellidos" => "Ribalta" ] 1 => array:2 [ "nombre" => "Carlos" "apellidos" => "Lahoz" ] 2 => array:2 [ "nombre" => "Xavier" "apellidos" => "Pintó" ] ] ] ] "titulosAlternativos" => array:1 [ "es" => array:1 [ "titulo" => "La asignación de factor impacto a Clínica e Investigación en Arteriosclerosis: ¡Un objetivo conseguido!" ] ] "textoCompleto" => "<span class="elsevierStyleSections"><p id="par0005" class="elsevierStylePara elsevierViewall">In an editorial published in the second issue of Clínica e Investigación en Arteriosclerosis last year, we stated that it could reasonably be foreseen that our journal would be assigned an impact factor in the near future. Our statement was largely based on the considerable improvement in the reference indices of Clínica e Investigación en Arteriosclerosis in recent years. Well, the prediction came true, and the official journal of the Spanish Society of Arteriosclerosis has had an impact factor since last June. The impact factor achieved by our journal based on data from the <span class="elsevierStyleItalic">Journal Citation Report</span>s™ (JCR), in the <span class="elsevierStyleItalic">Peripheral Artery Disease</span> category, is 1.6.</p><p id="par0010" class="elsevierStylePara elsevierViewall">Clínica e Investigación en Arteriosclerosis was assigned an impact factor for different reasons, the most important being the upward and sustained evolution in the number of citations over the last 10 years, as accredited by all the indicators (<span class="elsevierStyleItalic">CiteScore</span>, <span class="elsevierStyleItalic">Journal Citation Indicator</span>, <span class="elsevierStyleItalic">SCImago Journal Rank, and Source-Normalized Impact per Paper</span>). This resulted in Clínica e Investigación en Arteriosclerosis being included in the Emerging Sources Citation Index (ESCI) in 2018, which was the de facto prelude to obtaining the impact factor. From that moment on, the journal undertook a series of actions to ensure maximum options. These actions included a revamped cover image, the inclusion of a subheading (<span class="elsevierStyleItalic">La revista iberoamericana de lipidología y riesgo vascular</span>) to highlight the journal's role as a unifying force in these fields in Latin America, the renewal of the editorial boards following criteria of scientific excellence, generational turnover and parity, and the creation of new sections, such as methodological notes.</p><p id="par0015" class="elsevierStylePara elsevierViewall">Although all these actions have contributed, to a greater or lesser extent, to the success we enjoy today, special mention should be made of all the people who have worked hard and generously over the years to ensure that <span class="elsevierStyleItalic">Clínica e Investigación en Arteriosclerosis</span> has maintained an upward trend and was included in the Medline database in the first instance, and thus gained international renown. We would like to thank the different management teams of Clínica e Investigación en Arteriosclerosis, the professionals of the Elsevier publishing house, all the researchers who have published their studies in the journal, even when other options might have been more attractive to give visibility to their work, and these same people who with their work as reviewers have contributed to the improved quality of the articles. We would also like to thank the various boards of the Spanish Society of Arteriosclerosis for their tireless efforts in encouraging the publication of studies originating within the Society.</p><p id="par0020" class="elsevierStylePara elsevierViewall">A journal with an impact factor of 1.6 will undoubtedly attract more and better papers, which will increase the number of citations, an essential factor for moving up a quartile. Placing Clínica e Investigación en Arteriosclerosis in quartile 2 of its category is the new challenge and a realistic medium-term objective, which will give the Spanish Society of Arteriosclerosis an official journal with a scientific level on a par with the research conducted within it, and which is well deserved.</p></span>" "pdfFichero" => "main.pdf" "tienePdf" => true ] "idiomaDefecto" => "en" "url" => "/25299123/0000003500000004/v3_202311141613/S2529912323000554/v3_202311141613/en/main.assets" "Apartado" => array:4 [ "identificador" => "96084" "tipo" => "SECCION" "en" => array:2 [ "titulo" => "EDITORIALS" "idiomaDefecto" => true ] "idiomaDefecto" => "en" ] "PDF" => "https://static.elsevier.es/multimedia/25299123/0000003500000004/v3_202311141613/S2529912323000554/v3_202311141613/en/main.pdf?idApp=UINPBA00004N&text.app=https://www.elsevier.es/" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S2529912323000554?idApp=UINPBA00004N" ]
| Year/Month | Html | Total | |
|---|---|---|---|
| 2024 November | 2 | 0 | 2 |
| 2024 October | 6 | 2 | 8 |
| 2024 September | 19 | 3 | 22 |
| 2024 August | 17 | 4 | 21 |
| 2024 July | 8 | 3 | 11 |